Results 91 to 100 of about 1,906 (168)
Abstract Although inborn errors of metabolism (IEM) are a rare cause of epilepsy, seizures are a common presentation in these disorders. Seizures in IEM are frequently refractory to conventional anti‐seizure medication and might warrant initiation of specific treatments based on vitamins or dietary modifications or provision of alternative substrates ...
D. Kapoor +7 more
wiley +1 more source
Pyridoxine dependent epilepsy: a suggestive electroclinical pattern [PDF]
Editor—There are several problems with describing the electroclinical pattern in pyridoxine dependent seizures.1 One is defining the electrical features. Until now all published reports (including four of the five cases of Nabbout and colleagues) have described the electroencephalogram (EEG) in neonates who have received other anticonvulsants ...
openaire +1 more source
Current knowledge for pyridoxine-dependent epilepsy: a 2016 update
Pyridoxine-dependent epilepsy (PDE) is a rare genetic condition characterized by intractable and recurrent neonatal seizures that are uniquely alleviated by high doses of pyridoxine (vitamin B6). This recessive disease is caused by mutations in ALDH7A1, a gene encoding Antiquitin, an enzyme central to lysine degradation.
Pena, Izebella Agostinho +2 more
openaire +2 more sources
Neuropathological mechanisms of seizures in autism spectrum disorder
This manuscript reviews biological abnormalities shared by autism spectrum disorder (ASD) and epilepsy. Two neuropathological findings are shared by ASD and epilepsy: abnormalities in minicolumn architecture and -aminobutyric acid (GABA). The peripheral
Richard Eugene Frye +8 more
doaj +1 more source
Diagnostic pitfalls in vitamin B6‐dependent epilepsy caused by mutations in the PLPBP gene
Vitamin B6‐responsive epilepsies are a group of genetic disorders including ALDH7A1 deficiency, PNPO deficiency, and others, usually causing neonatal onset seizures resistant to treatment with common antiepileptic drugs.
Kristian Vestergaard Jensen +10 more
doaj +1 more source
ALDH7A1 encodes for the enzyme catalyzing the third step of the lysine degradation pathway. Biallelic pathogenic variants in ALDH7A1 are associated with pyridoxine dependent epilepsy (PDE), of which the c.1279G>C (p.Glu427Gln) variant is the most ...
Imke M.E. Schuurmans +4 more
doaj +1 more source
A Patient with Pyridoxine-Dependent Epilepsy Who Was Treated with Triple Therapy [PDF]
Minsun Ryu +3 more
doaj +1 more source
Clinical, biochemical, and molecular studies in pyridoxine‐dependent epilepsy. Antisense therapy as possible new therapeutic option [PDF]
Belén Pérez +19 more
openalex +1 more source
Association Between Lysine Reduction Therapies and Cognitive Outcomes in Patients With Pyridoxine-Dependent Epilepsy. [PDF]
Coughlin CR +23 more
europepmc +1 more source
2025 ACVIM Forum Research Abstract Program
Journal of Veterinary Internal Medicine, Volume 39, Issue 6, November/December 2025.
wiley +1 more source

